Scott Randal W. (CIK 1337801) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Buy BBIO (10,000 shares), Sell BBIO (6,200 shares), Sell BBIO (2,088 shares), Sell BBIO (1,512 shares), Sell BBIO (200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 10,000 | $167,500 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 6,200 | $413,464 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 2,088 | $141,003 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,512 | $103,164 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 200 | $13,824 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 10,000 | $167,500 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,900 | $141,246 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 4,793 | $362,207 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 3,307 | $251,101 |
| 2025-11-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 10,000 | $167,500 |
| 2025-11-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 3,801 | $251,816 |
| 2025-11-19 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 6,199 | $414,651 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
Source: SEC Form 4 filings · as of 2026-05-19